- Home
- KYTX vs BDTX Comparison
KYTX vs BDTX Comparison
Compare KYTX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- BDTX
- Stock Information
- Founded
- KYTX 2018
- BDTX 2014
- Country
- KYTX United States
- BDTX United States
- Employees
- KYTX N/A
- BDTX 54
- Industry
- KYTX
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KYTX
- BDTX Health Care
- Exchange
- KYTX NYSE
- BDTX Nasdaq
- Market Cap
- KYTX 166.4M
- BDTX 126.8M
- IPO Year
- KYTX 2024
- BDTX 2020
- Fundamental
- Price
- KYTX $3.41
- BDTX $2.36
- Analyst Decision
- KYTX Buy
- BDTX Strong Buy
- Analyst Count
- KYTX 5
- BDTX 4
- Target Price
- KYTX $23.20
- BDTX $15.50
- AVG Volume (30 Days)
- KYTX 308.0K
- BDTX 1.2M
- Earning Date
- KYTX 02-12-2025
- BDTX 03-11-2025
- Dividend Yield
- KYTX N/A
- BDTX N/A
- EPS Growth
- KYTX N/A
- BDTX N/A
- EPS
- KYTX N/A
- BDTX N/A
- Revenue
- KYTX N/A
- BDTX N/A
- Revenue This Year
- KYTX N/A
- BDTX N/A
- Revenue Next Year
- KYTX N/A
- BDTX N/A
- P/E Ratio
- KYTX N/A
- BDTX N/A
- Revenue Growth
- KYTX N/A
- BDTX N/A
- 52 Week Low
- KYTX $3.22
- BDTX $1.91
- 52 Week High
- KYTX $30.60
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- KYTX 37.34
- BDTX 51.35
- Support Level
- KYTX $3.22
- BDTX $2.10
- Resistance Level
- KYTX $3.53
- BDTX $2.33
- Average True Range (ATR)
- KYTX 0.25
- BDTX 0.17
- MACD
- KYTX 0.00
- BDTX 0.04
- Stochastic Oscillator
- KYTX 13.46
- BDTX 52.63
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.